Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Mackay, A. V. P.
1980.
Positive and Negative Schizophrenic Symptoms and the Role of Dopamine.
British Journal of Psychiatry,
Vol. 137,
Issue. 4,
p.
379.
Crow, T. J.
1980.
Positive and Negative Schizophrenic Symptoms and the Role of Dopamine.
British Journal of Psychiatry,
Vol. 137,
Issue. 4,
p.
383.
Kennedy, Peter
1980.
The Use of Psychiatric Drugs for Decades.
British Journal of Psychiatry,
Vol. 137,
Issue. 4,
p.
387.
Freeman, Hugh L.
1981.
Long-term treatment of schizophrenia.
Comprehensive Psychiatry,
Vol. 22,
Issue. 1,
p.
94.
Johnstone, Eve C.
Owens, D. G. Cunningham
Gold, Aviva
Crow, T. J.
and
Macmillan, J. Fiona
1981.
Institutionalization and the Defects of Schizophrenia.
British Journal of Psychiatry,
Vol. 139,
Issue. 3,
p.
195.
Crow, T. J.
1981.
Positive and Negative Schizophrenia Symptoms and the Role of Dopamine.
British Journal of Psychiatry,
Vol. 139,
Issue. 3,
p.
251.
Schiff, A. A.
1981.
Drug Side-Effects and Brain Damage.
British Journal of Psychiatry,
Vol. 139,
Issue. 5,
p.
473.
Crow, T.J.
1982.
Two syndromes in schizophrenia?.
Trends in Neurosciences,
Vol. 5,
Issue. ,
p.
351.
Katona, C.
1982.
Institutionalization and the Defects of Schizophrenia.
British Journal of Psychiatry,
Vol. 140,
Issue. 2,
p.
211.
Crow, T. J.
1982.
The biology of schizophrenia.
Experientia,
Vol. 38,
Issue. 11,
p.
1275.
McCreadie, Robin G.
1982.
The Nithsdale Schizophrenia Survey: I. Psychiatric and Social Handicaps.
British Journal of Psychiatry,
Vol. 140,
Issue. 6,
p.
582.
Crow, T.J.
1982.
Chemical Transmission in the Brain: The Role of Amines, Amino Acids and Peptides, Proceedings of the 12th International Summer School of Brain Research, held at the Royal Netherlands Academy of Arts and Sciences.
Vol. 55,
Issue. ,
p.
407.
Ferrier, I. N.
Cotes, P. M.
Crow, T. J.
and
Johnstone, E. C.
1982.
Gonadotrophin secretion abnormalities in chronic schizophrenia.
Psychological Medicine,
Vol. 12,
Issue. 2,
p.
263.
FERRIER, I. N.
ARENDT, J.
JOHNSTONE, E. C.
and
CROW, T. J.
1982.
REDUCED NOCTURNAL MELATONIN SECRETION IN CHRONIC SCHIZOPHRENIA: RELATIONSHIP TO BODY WEIGHT.
Clinical Endocrinology,
Vol. 17,
Issue. 2,
p.
181.
Bishop, Robert J.
Golden, Charles J.
Maclnnes, William D.
Chu, Chung-Chou
Ruedrich, Stephen L.
and
Wilson, James
1983.
The BPRS is assessing symptom correlates of cerebral ventricular enlargement in acute and chronic schizophrenia.
Psychiatry Research,
Vol. 9,
Issue. 3,
p.
225.
Allen, Heidelinde A.
1983.
Do positive symptom and negative symptom subtypes of schizophrenia show qualitative differences in language production?.
Psychological Medicine,
Vol. 13,
Issue. 4,
p.
787.
Nicol Ferrier, I.
Roberts, Gareth W.
Crow, Timothy J.
Johnstone, Eve C.
Owens, David G.C.
Lee, Ying C.
O'Shaughnessy, David
Adrian, Tom E.
Polak, Julia M.
and
Bloom, Stephen R.
1983.
Reduced cholecystokinin-like and somatostatin-like immunoreactivity in limbic lobe is associated with negative symptoms in schizophrenia.
Life Sciences,
Vol. 33,
Issue. 5,
p.
475.
Johnson, D. A. W.
Pasterski, G.
Ludlow, J. M.
Street, K.
and
Taylor, R. D. W.
1983.
The discontinuance of maintenance neuroleptic therapy in chronic schizophrenic patients: drug and social consequences.
Acta Psychiatrica Scandinavica,
Vol. 67,
Issue. 5,
p.
339.
Ferrer, I. N.
Johnstone, E. C.
and
Crow, T. J.
1984.
Clinical Effects of Apomorphine in Schizophrenia.
British Journal of Psychiatry,
Vol. 144,
Issue. 4,
p.
341.
Liddle, P. F.
and
Crow, T. J.
1984.
Age Disorientation in Chronic Schizophrenia is Associated with Global Intellectual Impairment.
British Journal of Psychiatry,
Vol. 144,
Issue. 2,
p.
193.
eLetters
No eLetters have been published for this article.